# Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion

> **NCT04254081** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 57 (actual)

## Conditions studied

- Procedural Pain
- Buprenorphine
- Adjuvants, Anesthesia
- Dilation and Evacuation
- Analgesics

## Interventions

- **DRUG:** Buprenorphine 0.15 MG
- **DRUG:** Lidocaine 1% Injectable Solution

## Key facts

- **NCT ID:** NCT04254081
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-28
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254081, "Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04254081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*